Exane Derivatives’s Regency Centers REG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$712 Hold
12
﹤0.01% 538
2022
Q1
$856 Hold
12
﹤0.01% 815
2021
Q4
$904 Hold
12
﹤0.01% 719
2021
Q3
$808 Hold
12
﹤0.01% 887
2021
Q2
$777 Hold
12
﹤0.01% 899
2021
Q1
$680 Hold
12
﹤0.01% 766
2020
Q4
$547 Hold
12
﹤0.01% 734
2020
Q3
$456 Hold
12
﹤0.01% 686
2020
Q2
$551 Hold
12
﹤0.01% 605
2020
Q1
$461 Hold
12
﹤0.01% 607
2019
Q4
$756 Hold
12
﹤0.01% 568
2019
Q3
$834 Hold
12
﹤0.01% 549
2019
Q2
$801 Hold
12
﹤0.01% 567
2019
Q1
$810 Hold
12
﹤0.01% 512
2018
Q4
$704 Buy
12
+1
+9% +$63 ﹤0.01% 587
2018
Q3
$701 Buy
+11
New +$701 ﹤0.01% 565
2017
Q4
Sell
-1
Closed -$62 632
2017
Q3
$62 Sell
1
-2
-67% -$129 ﹤0.01% 529
2017
Q2
$188 Buy
+3
New +$189 ﹤0.01% 541
2017
Q1
Sell
-10,392
Closed -$716K 654
2016
Q4
$716K Buy
10,392
+10,391
+1,039,100% +$724K 0.14% 127
2016
Q3
$77 Hold
1
﹤0.01% 549
2016
Q2
$84 Sell
1
-603
-100% -$46.4K ﹤0.01% 476
2016
Q1
$45.2K Buy
+604
New +$43.2K 0.01% 329

Other funds holding REG

Exane Derivatives's REG Position: Q2 2022 in Review

Exane Derivatives held its Regency Centers (REG) position steady in Q2 2022 at 12 shares worth $712. The position accounts for ﹤0.01% of the portfolio, ranked #538.

Exane Derivatives first reported a position in REG in Q1 2016 and has held it in 22 quarters since. The position peaked at $716K in Q4 2016. 388 funds tracked by Wall St. Rank hold REG as of Q2 2022.

  • Exane Derivatives held 12 shares of Regency Centers worth $712 as of Q2 2022.
  • Exane Derivatives left its Regency Centers share count unchanged in Q2 2022.
  • Regency Centers made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #538 holding.
  • Exane Derivatives first reported a position in Regency Centers in Q1 2016 and has held it in 22 quarters since.
  • Exane Derivatives's Regency Centers position peaked at $716K in Q4 2016.
  • 388 funds tracked by Wall St. Rank held Regency Centers as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.